{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:58:45Z","timestamp":1782845925670,"version":"3.54.5"},"reference-count":35,"publisher":"JMIR Publications Inc.","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Internet Res"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Multiple sclerosis (MS) is a chronic neurological disease occurring mostly in women of childbearing age. Pregnant women with MS are usually excluded from clinical trials; as users of the internet, however, they are actively engaged in threads and forums on social media. Social media provides the potential to explore real-world patient experiences and concerns about the use of medicinal products during pregnancy and breastfeeding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to analyze the content of posts concerning pregnancy and use of medicines in online forums; thus, the study aimed to gain a thorough understanding of patients\u2019 experiences with MS medication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using the names of medicinal products as search terms, we collected posts from 21 publicly available pregnancy forums, which were accessed between March 2015 and March 2018. After the identification of relevant posts, we analyzed the content of each post using a content analysis technique and categorized the main topics that users discussed most frequently.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 6 main topics in 70 social media posts. These topics were as follows: (1) expressing personal experiences with MS medication use during the reproductive period (55\/70, 80%), (2) seeking and sharing advice about the use of medicines (52\/70, 74%), (3) progression of MS during and after pregnancy (35\/70, 50%), (4) discussing concerns about MS medications during the reproductive period (35\/70, 50%), (5) querying the possibility of breastfeeding while taking MS medications (30\/70, 42%), and (6) commenting on communications with physicians (26\/70, 37%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Overall, many pregnant women or women considering pregnancy shared profound uncertainties and specific concerns about taking medicines during the reproductive period. There is a significant need to provide advice and guidance to MS patients concerning the use of medicines in pregnancy and postpartum as well as during breastfeeding. Advice must be tailored to the circumstances of each patient and, of course, to the individual medicine. Information must be provided by a trusted source with relevant expertise and made publicly available.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/13003","type":"journal-article","created":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T13:32:47Z","timestamp":1561815167000},"page":"e13003","source":"Crossref","is-referenced-by-count":24,"title":["Social Media Surveillance of Multiple Sclerosis Medications Used During Pregnancy and Breastfeeding: Content Analysis"],"prefix":"10.2196","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6351-8235","authenticated-orcid":false,"given":"Bita","family":"Rezaallah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9576-3489","authenticated-orcid":false,"given":"David John","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1276-9250","authenticated-orcid":false,"given":"Carrie","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3256-6108","authenticated-orcid":false,"given":"Hans-Florian","family":"Zeilhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4267-0761","authenticated-orcid":false,"given":"Britt-Isabelle","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2019,8,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/400_2009_19"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/1756285616631897"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70064-8"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2011.02931.x"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2217\/whe.12.33"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318224afc9"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2011.3118"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/2168479018761638"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.8164"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-016-0491-0"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12717"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.2939"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-015-0385-6"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-014-0155-x"},{"key":"ref15","unstructured":"MedDRAMedical Dictionary for Regulatory Activities \n        https:\/\/www.meddra.org\/"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.9870"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/nhs.12048"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-002594"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.midw.2007.01.010"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-536X.2010.00390.x"},{"key":"ref21","unstructured":"US Food and Drug Administration2014Pregnancy, Lactation, and Reproductive Potential: Labeling for Human Prescription Drug and Biological Products \u2014 Content and Format, Guidance for Industry (Draft) \n        https:\/\/www.fda.gov\/media\/90160\/download"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.676"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092744"},{"key":"ref24","unstructured":"US Food and Drug AdministrationHighlights of Prescribing Information \n        https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/022527s024lbl.pdf"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2018.06.006"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2018-001053"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2012.04332.x"},{"key":"ref28","unstructured":"IMI: Innovative Medicines Initiative2017Topic: ConcePTION \u2013 Continuum of Evidence from Pregnancy Exposures, Reproductive Toxicology and Breastfeeding to Improve Outcomes Now \n        https:\/\/tinyurl.com\/yxdty257"},{"key":"ref29","unstructured":"European Medicines Agency2019PRAC recommends new measures to avoid valproate exposure in pregnancy \n        https:\/\/www.ema.europa.eu\/en\/news\/prac-recommends-new-measures-avoid-valproate-exposure-pregnancy"},{"issue":"Suppl 6","key":"ref30","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1528-1157.1999.tb00925.x","volume":"40","author":"Loiseau, P","year":"1999","journal-title":"Epilepsia"},{"key":"ref31","unstructured":"European Medicines Agency200511Guideline on the Exposure to Medicinal Products During Pregnancy Need for Post-Authorisation Data \n        https:\/\/tinyurl.com\/y5l8x8a5"},{"key":"ref32","unstructured":"US Food and Drug Administration200504Evaluating the Risks of Drug Exposure in Human Pregnancies \n        https:\/\/www.fda.gov\/downloads\/Drugs\/Guidances\/ucm071645.pdf"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.30313"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2018.1531847"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-016-1691-0"}],"container-title":["Journal of Medical Internet Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jmir.org\/2019\/8\/e13003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:00:42Z","timestamp":1782842442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmir.org\/2019\/8\/e13003\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,7]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2196\/13003","relation":{"has-preprint":[{"id-type":"doi","id":"10.2196\/preprints.13003","asserted-by":"object"}]},"ISSN":["1438-8871"],"issn-type":[{"value":"1438-8871","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,7]]}}}